Evidence map›Paper›PMID 31645437›Full record

ReviewThe Journal of biological chemistry2019

Regulation of large and small G proteins by ubiquitination.

Henrik G Dohlman, Sharon L Campbell

Open access · hybridAbstract readReview
In one paragraph

Review in The Journal of biological chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Biomarker Landscape in RASopathies.International journal of molecular sciences · 2024
    Review
  6. Article
  7. Molecules (Basel, Switzerland) · 2023
    Article
  8. Review
  9. Dynamic regulation of RAS and RAS signaling.The Biochemical journal · 2023
    Article
  10. Role of G-Proteins and GPCRs in Cardiovascular Pathologies.Bioengineering (Basel, Switzerland) · 2023
    Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Post-translational modification of RAS proteins.Current opinion in structural biology · 2021
    Review
  16. Article
  17. Review
  18. Review
  19. Interaction between Peptidyl-prolylJournal of cancer prevention · 2020
    Article
  20. ERK/MAPK signalling pathway and tumorigenesis.Experimental and therapeutic medicine · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Henrik G DohlmanDepartment of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599. Electronic address: hdohlman@med.unc.edu.
Sharon L CampbellDepartment of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599. Electronic address: campbesl@med.unc.edu.
University of North Carolina at Chapel Hill · US

Funding

Project 4: The role of codon bias in RAS tumorigenesisP01CA203657 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI COUNTER, CHRISTOPHER M · 2016 to 2020
$7.9M
Negative and positive feedback in cell signalingR35GM118105 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Henrik G. Dohlman · 2016 to 2026
$6.6M
Structure and Mechanism of G-proteins and cell adhesion proteins in regulation of cell growth and motilityR35GM134962 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Sharon L Campbell · 2020 to 2026
$4.2M
Structure and function of novel G protein conformationsR01GM114130 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CAMPBELL, SHARON L · 2016 to 2018
$934k
NCI NIH HHS P01 CA203657NIGMS NIH HHS R01 GM114130NIGMS NIH HHS R35 GM118105NIGMS NIH HHS R35 GM134962
6 · The paper itself

Abstract

Many sensory and chemical signal inputs are transmitted by intracellular GTP-binding (G) proteins. G proteins make up two major subfamilies: "large" G proteins comprising three subunits and "small" G proteins, such as the proto-oncogene product RAS, which contains a single subunit. Members of both subfamilies are regulated by post-translational modifications, including lipidation, proteolysis, and carboxyl methylation. Emerging studies have shown that these proteins are also modified by ubiquitination. Much of our current understanding of this post-translational modification comes from investigations of the large G-protein α subunit from yeast (Gpa1) and the three RAS isotypes in humans, NRAS, KRAS, and HRAS. Gα undergoes both mono- and polyubiquitination, and these modifications have distinct consequences for determining the sites and mechanisms of its degradation. Genetic and biochemical reconstitution studies have revealed the enzymes and binding partners required for addition and removal of ubiquitin, as well as the delivery and destruction of both the mono- and polyubiquitinated forms of the G protein. Complementary studies of RAS have identified multiple ubiquitination sites, each having distinct consequences for binding to regulatory proteins, shuttling to and from the plasma membrane, and degradation. Here, we review what is currently known about these two well-studied examples, Gpa1 and the human RAS proteins, that have revealed additional mechanisms of signal regulation and dysregulation relevant to human physiology. We also compare and contrast the effects of G-protein ubiquitination with other post-translational modifications of these proteins.

Indexed as

AnimalsCysteine EndopeptidasesGTP-Binding ProteinsHumansMonomeric GTP-Binding ProteinsProto-Oncogene Masras ProteinsUbiquitinUbiquitin-Protein LigasesCysteine EndopeptidasesGTP-Binding ProteinsMAS1 protein, humanMonomeric GTP-Binding ProteinsProto-Oncogene Masras ProteinsUbiquitinUbiquitin-Protein LigasesCdc34E3 ligaseE3 ubiquitin ligaseG proteinOTUB1Rabex-5Ras proteinubiquitinUbp12yeast

Identifiers

PMID31645437
PMCPMC6901297
OpenAlexW2981819533

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.